Related Experiment Video
Updated: Jun 13, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Modern treatment programs for adults with acute lymphoblastic leukemia
Farhad Ravandi1, Stefan Faderl, Partow Kebriaei
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. fravandi@mdanderson.org
Current Hematologic Malignancy Reports
|April 29, 2010
Summary
Adult acute lymphoblastic leukemia treatment, modeled on pediatric care, achieves remission but often relapses. New targeted therapies and minimal residual disease monitoring offer hope for improved outcomes through personalized strategies.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Current adult acute lymphoblastic leukemia (ALL) treatments are adapted from pediatric protocols.
- While achieving comparable remission rates to children, adult ALL patients frequently experience relapse.
- Existing salvage therapies for relapsed adult ALL demonstrate limited efficacy.
Purpose of the Study:
- To review current treatment strategies for adult acute lymphoblastic leukemia (ALL).
- To highlight the impact of molecular biology advances on ALL therapy.
- To discuss the potential of targeted agents and minimal residual disease monitoring for improving patient outcomes.
Main Methods:
- Review of current treatment paradigms for adult acute lymphoblastic leukemia (ALL).
- Analysis of recent advances in molecular biology and targeted therapies.
- Evaluation of minimal residual leukemia detection techniques.
Main Results:
- Pediatric-based regimens yield high remission rates in adults but are followed by significant relapse.
- Targeted agents like tyrosine kinase inhibitors and monoclonal antibodies show promise in specific adult ALL subsets.
- Minimal residual leukemia monitoring aids in predicting relapse and guiding early intervention.
Conclusions:
- Refining therapeutic approaches for adult acute lymphoblastic leukemia (ALL) is crucial.
- Translating molecular discoveries into risk-adapted strategies will improve patient outcomes.
- Personalized medicine incorporating targeted therapies and MRD monitoring is the future of adult ALL treatment.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...